Kate Liebelt, Chief of Staff to R&D Leadership Team | Executive Director, Organon & Executive in Residence – Women’s Health Innovation, Springboard Enterprises

Kate has spent the last 20 years helping organizations bring innovative products and services to market as both a corporate leader and entrepreneur. Her experience spans life sciences and health care across academia, industry and non-profits. R&D roles at Organon, AbbVie, Takeda, Organon, Baxter, TAP and Washington University in Saint Louis’s Office of Technology Transfer have positioned Kate well to help innovative teams think through the complexities of launching a new product or service in terms of planning, budgeting, and measuring progress.

Kate is a seasoned start-up and not-for-profit board member. She has been recognized for her entrepreneur advocacy and civic engagement by Springboard Enterprises and Becker’s Hospital Review. She is a published author and public speaker, as well as a graduate school instructor. Kate earned a B.A. in economics from Washington University in Saint Louis, certificate in healthcare innovation from the University of Pennsylvania, and certificate in cancer genomics and precision oncology, Harvard University Medical School.